DERM US and EU Validation Study

Completed

Conditions studied: Malignant Skin Melanoma T0, Basal Cell Carcinoma, Squamous Cell Carcinoma

In brief

This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.

Key facts

Study ID
NCT05126173
Run by
Skin Analytics Limited
People needed
1111
Starts
2022-03-15
Expected to finish
2022-09-15
Last updated by the study team
2023-06-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.